Teva Pharmaceutical Industries (NYSE:TEVA) earnings and shareholder returns have been trending downwards for the last five years, but the stock lifts 3.6% this past week
Is Teva Pharmaceutical Industries Limited's (NYSE:TEVA) 4.1% ROE Worse Than Average?
Does Teva Pharmaceutical Industries (NYSE:TEVA) Have A Healthy Balance Sheet? - Simply Wall St News
Teva Shares Nyse Flash Sales, 51% OFF | edetaria.com